| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.79B | 49.83B | 40.32B | 44.67B | 37.50B | 41.15B |
| Gross Profit | 48.48B | 46.96B | 38.67B | 43.27B | 37.26B | 40.84B |
| EBITDA | 3.51B | 10.32B | 7.89B | 6.15B | 5.95B | 5.84B |
| Net Income | 6.36B | 5.66B | 4.54B | 3.29B | 3.18B | 2.72B |
Balance Sheet | ||||||
| Total Assets | 3.57T | 3.46T | 3.58T | 3.53T | 3.67T | 3.49T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 466.75B | 688.70B | 754.30B | 843.45B | 789.28B |
| Total Debt | 90.81B | 87.39B | 209.09B | 196.25B | 289.31B | 248.49B |
| Total Liabilities | 3.40T | 3.30T | 3.41T | 3.38T | 3.50T | 3.31T |
| Stockholders Equity | 166.66B | 156.36B | 172.07B | 149.26B | 167.18B | 175.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -131.80B | -53.74B | -168.20B | 201.26B | 0.00 |
| Operating Cash Flow | 0.00 | -130.49B | -52.39B | -167.14B | 203.31B | 0.00 |
| Investing Cash Flow | 0.00 | -87.85B | -12.57B | 80.25B | -145.54B | -40.25B |
| Financing Cash Flow | 0.00 | -1.48B | -1.11B | -1.88B | -1.25B | 277.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥101.82B | 1.54 | ― | 3.05% | 8.75% | -12.68% | |
71 Outperform | ¥83.25B | 5.15 | ― | 2.49% | 7.08% | -46.44% | |
68 Neutral | ¥82.34B | 10.96 | ― | 2.89% | -0.24% | 95.49% | |
68 Neutral | ¥86.85B | 7.94 | ― | 2.29% | 7.97% | 20.44% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | ¥98.23B | 7.75 | ― | 3.35% | 15.96% | 81.27% | |
52 Neutral | ¥99.55B | 6.95 | ― | 2.12% | 10.91% | -1225.48% |